Oxford Immunotec loses bid to block rival's blood test on patent grounds

U.S. District Judge Nathaniel Gorton in Boston on Tuesday declined to grant Oxford a preliminary injunction that would block Qiagen from selling its product to new customers currently using tuberculin skin tests.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2fSvwyE